Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common liver
disease globally and is currently estimated to affect 38% of the global population. Only a …

Excess body weight is a global health problem due to sedentary lifestyle and unhealthy diet,
affecting 2 billion population worldwide. Obesity is a major risk factor for metabolic diseases …

Background Observational studies suggest that bariatric–metabolic surgery might greatly
improve non-alcoholic steatohepatitis (NASH). However, the efficacy of surgery on NASH …

Background Malnutrition and obesity are interdependent pathologies along the same
spectrum. We examined global trends and projections of disability-adjusted life years …

Background A significant proportion of premature deaths globally are related to metabolic
diseases in young adults. We examined the global trends and mortality of metabolic …

Introduction Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver
disease, with type 2 diabetes mellitus (T2DM) as a major predictor. Insulin resistance and …

Background Recent studies suggest that tirzepatide, a dual glucose-dependent
insulinotropic-peptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA), has …

Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of fatty liver disease,
including non-alcoholic fatty liver (NAFL) and its more progressive form, non-alcoholic …

Abstract Ethnopharmacological relevance Zanthoxylum bungeanum Maxim.(Rutaceae) is a
known herbal medicine with various bioactivities, including anti-obesity, lipid-lowering …

Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) refers to the accumulation of lipid laden
vacuoles in hepatocytes, occurring in the context of visceral adiposity, insulin resistance and …